# Acrivon Therapeutics, Inc. Common Stock (ACRV): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/acrv for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company primarily focused on creating oncology treatments. The firm employs a unique strategy to identify patients whose tumors are predicted to be sensitive to specific medications, utilizing its proprietary proteomics-based platform for patient identification. This advanced system, named Acrivon Predictive Precision Proteomics (AP3), serves as a precision medicine tool. It is instrumental in developing drug-specific OncoSignature companion diagnostics, which are designed to pinpoint individuals most likely to benefi...

## Quote & Key Metrics

As of 2026-10-22:

| Metric | Value |
|---|---|
| Price | $1.76 USD |
| Market Cap | $75.4M |
| P/E (TTM) | — |
| EPS (TTM) | −$1.88 |
| 52-Week Range | $1.27 – $3.56 |
| Dividend Yield (TTM) | — |

## Dividend

ACRV has no dividend payment history in our records.

## Frequently Asked Questions

### What does Acrivon Therapeutics, Inc. Common Stock do?

Acrivon Therapeutics, Inc. Common Stock (ACRV) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is ACRV's market cap?

Acrivon Therapeutics, Inc. Common Stock (ACRV) has a market capitalization of approximately $75.4 million, as of October 22, 2026, based on the most recent share price and shares outstanding.

### Does ACRV pay a dividend?

No, Acrivon Therapeutics, Inc. Common Stock (ACRV) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is ACRV profitable?

Acrivon Therapeutics, Inc. Common Stock (ACRV) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has ACRV ever paid a dividend?

No. Dividend Data's records show no dividend payments from Acrivon Therapeutics, Inc. Common Stock (ACRV). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/acrv
- Dividend history & safety: https://www.dividenddata.com/stocks/acrv/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/acrv/earnings
- Financial statements: https://www.dividenddata.com/stocks/acrv/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/acrv/valuation
- Peer comparison: https://www.dividenddata.com/stocks/acrv/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.